SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001628280-26-001817 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 12, 2026 |
| Document Date | Jan 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
30,000
Total Value
$194,700.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 9, 2026 | Exercise/Conversion | 15,000 | $12.98 | $194,700.00 | 61,307 | Direct | โ | View Details | |
Director | Director Stock Option (Right to Buy) | Derivative | Jan 9, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |